blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1551415

EP1551415 - ORAL PHARMACEUTICAL COMPOSITION COMPRISING 15-HYDROXYTESTOSTERONE AND ITS ANALOGUES [Right-click to bookmark this link]
Former [2005/28]PHARMACEUTICAL APPLICATION OF 15- OR 16- SUBSTITUTED TESTOSTERONE ANALOGUES
[2009/26]
StatusNo opposition filed within time limit
Status updated on  29.10.2010
Database last updated on 20.07.2024
Most recent event   Tooltip14.01.2011Lapse of the patent in a contracting state
New state(s): DK		published on 16.02.2011  [2011/07]
Applicant(s)For all designated states
Pantarhei Bioscience B.V.
P.O. Box 464
3700 AL Zeist / NL
[2005/28]
Inventor(s)01 / BUNSCHOTEN, Evert, Johannes
Plantsoen 16
NL-5384 EV Heesch / NL
02 / COELINGH BENNINK, Herman, Jan, Tijmen
Duinroos 3
2202 Da Noordwijk / NL
03 / VAN DER LINDEN, René, Frank
Amersfoortseweg 4
NL-3951 LB Maarn / NL
 [2007/09]
Former [2005/28]01 / BUNSCHOTEN, Evert, Johannes
Plantsoen 16
NL-5384 EV Heesch / NL
02 / COELINGH BENNINK, Herman, Jan, Tijmen
Melvill van Carnbeelaan 38
NL-3971 BE Driebergen / NL
03 / VAN DER LINDEN, René, Frank
Amersfoortseweg 4
NL-3951 LB Maarn / NL
Representative(s)van Westenbrugge, Andries
Nederlandsch Octrooibureau
P.O. Box 29720
NL-2502 LS The Hague / NL
[N/P]
Former [2008/22]van Westenbrugge, Andries
Postbus 29720
2502 LS Den Haag / NL
Former [2005/28]van Westenbrugge, Andries
Nederlandsch Octrooibureau Postbus 29720
2502 LS Den Haag / NL
Application number, filing date03794351.105.09.2003
WO2003NL00621
Priority number, dateEP2002007864305.09.2002         Original published format: EP 02078643
[2005/28]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2004022065
Date:18.03.2004
Language:EN
[2004/12]
Type: A1 Application with search report 
No.:EP1551415
Date:13.07.2005
Language:EN
The application published by WIPO in one of the EPO official languages on 18.03.2004 takes the place of the publication of the European patent application.
[2005/28]
Type: B1 Patent specification 
No.:EP1551415
Date:23.12.2009
Language:EN
[2009/52]
Search report(s)International search report - published on:EP18.03.2004
ClassificationIPC:A61K31/56
[2005/28]
CPC:
A61K31/56 (EP,US); A61K31/565 (EP,US); A61K31/568 (EP,US);
A61P15/00 (EP); A61P15/16 (EP); A61P5/26 (EP)
C-Set:
A61K31/565, A61K2300/00 (US,EP);
A61K31/568, A61K2300/00 (US,EP);
A61K31/56, A61K2300/00 (EP,US)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   RO,   SE,   SI,   SK,   TR [2005/28]
Former [N/P]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HU,  IE,  IT,  LI,  LU,  MC,  NL,  PT,  RO,  SE,  SI,  SK,  TR 
Extension statesALNot yet paid
LTNot yet paid
LVNot yet paid
MKNot yet paid
TitleGerman:ORALE PHARMAZEUTISCHE ZUSAMMENSETZUNG ENTHALTEND 15-HYDROXYTESTOSTERON UND SEINE DERIVATE[2009/26]
English:ORAL PHARMACEUTICAL COMPOSITION COMPRISING 15-HYDROXYTESTOSTERONE AND ITS ANALOGUES[2009/26]
French:COMPOSITION PHARMACEUTIQUE POUR L'ADMINISTRATION ORALE COMPRENANT 15-HYDROXYTESTOSTERONE ET SES ANALOGUES[2009/26]
Former [2005/28]PHARMAZEUTISCHE ANWENDUNG VON 15- ODER 16- SUBSTITUIERTEN TESTOSTERON-ANALOGA
Former [2005/28]PHARMACEUTICAL APPLICATION OF 15- OR 16- SUBSTITUTED TESTOSTERONE ANALOGUES
Former [2005/28]APPLICATION PHARMACEUTIQUE D'ANALOGUES DE TESTOSTERONE A SUBSTITUTION 15 OU 16
Entry into regional phase07.03.2005National basic fee paid 
07.03.2005Designation fee(s) paid 
07.03.2005Examination fee paid 
Examination procedure07.03.2005Examination requested  [2005/28]
07.10.2005Despatch of a communication from the examining division (Time limit: M06)
11.04.2006Reply to a communication from the examining division
10.03.2008Despatch of a communication from the examining division (Time limit: M04)
31.03.2008Reply to a communication from the examining division
15.06.2009Cancellation of oral proceeding that was planned for 26.08.2009
15.06.2009Minutes of oral proceedings despatched
09.07.2009Communication of intention to grant the patent
27.07.2009Date of oral proceedings
26.08.2009Date of oral proceedings
26.08.2009Date of oral proceedings (cancelled)
09.11.2009Fee for grant paid
09.11.2009Fee for publishing/printing paid
Opposition(s)24.09.2010No opposition filed within time limit [2010/48]
Fees paidRenewal fee
31.08.2005Renewal fee patent year 03
31.08.2006Renewal fee patent year 04
13.08.2007Renewal fee patent year 05
31.03.2008Renewal fee patent year 06
31.07.2009Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT23.12.2009
BE23.12.2009
CY23.12.2009
CZ23.12.2009
DK23.12.2009
EE23.12.2009
FI23.12.2009
RO23.12.2009
SE23.12.2009
SI23.12.2009
SK23.12.2009
BG23.03.2010
GR24.03.2010
PT23.04.2010
[2011/07]
Former [2010/49]AT23.12.2009
BE23.12.2009
CY23.12.2009
CZ23.12.2009
EE23.12.2009
FI23.12.2009
RO23.12.2009
SE23.12.2009
SI23.12.2009
SK23.12.2009
BG23.03.2010
GR24.03.2010
PT23.04.2010
Former [2010/39]AT23.12.2009
BE23.12.2009
CZ23.12.2009
EE23.12.2009
FI23.12.2009
RO23.12.2009
SE23.12.2009
SI23.12.2009
SK23.12.2009
BG23.03.2010
PT23.04.2010
Former [2010/37]AT23.12.2009
BE23.12.2009
CZ23.12.2009
EE23.12.2009
FI23.12.2009
RO23.12.2009
SE23.12.2009
SI23.12.2009
BG23.03.2010
PT23.04.2010
Former [2010/36]AT23.12.2009
CZ23.12.2009
EE23.12.2009
FI23.12.2009
RO23.12.2009
SE23.12.2009
SI23.12.2009
BG23.03.2010
PT23.04.2010
Former [2010/35]AT23.12.2009
EE23.12.2009
FI23.12.2009
RO23.12.2009
SE23.12.2009
SI23.12.2009
BG23.03.2010
PT23.04.2010
Former [2010/30]AT23.12.2009
FI23.12.2009
SE23.12.2009
SI23.12.2009
Former [2010/23]FI23.12.2009
SE23.12.2009
SI23.12.2009
Former [2010/22]FI23.12.2009
SE23.12.2009
Cited inInternational search[X]GB774064  (UPJOHN CO) [X] 1-5,7-9,11-15 * claim 2 * * page 1, line 19 - line 20 * * page 3, line 66 - line 70 *;
 [X]FR2035786  (SQUIBB & SONS INC) [X] 1,7-9,11-15 * claims 1,3,7,8 * * page 1, line 38 *;
 [A]US6117446  (PLACE VIRGIL A [US]) [A] * claims 1,2 *;
 [A]WO0074684  (GEN HOSPITAL CORP [US], et al) [A] * claims 1,6 *;
 [X]WO0123405  (HOLLIS EDEN PHARMACEUTICALS [US]) [X] 1-9,11-15 * claims 1,2 *
Examination   - ALLEN G R, WEISS M J, "The reaction of alkoxalylated steroid ketones with dibenzoyl peroxide. A synthesis of 16beta-hydroxytestosterone", JOURNAL OF ORGANIC CHEMISTRY, (1962), vol. 27, pages 4681 - 4682
    - YAMASHITA H. ET AL., "Microbial 16beta-hydroxylation of steroids with Aspergillus niger", AGRICULTURAL AND BIOLOGICAL CHEMISTRY, (1976), vol. 40, no. 3, pages 505 - 509, XP009089217
    - ROSENBROCK H. ET AL., "Testosterone metabolism in rat brain is differentially enhanced by phenytoin-inducible cytochrome P450 isoforms", JOURNAL OF NEUROENDOCRINOLOGY, (1999), vol. 11, pages 597 - 604
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.